Elaboration of a proprietary thymidylate kinase inhibitor motif towards anti-tuberculosis agents was written by Song, Lijun;Risseeuw, Martijn D. P.;Froeyen, Matheus;Karalic, Izet;Goeman, Jan;Cappoen, Davie;Van der Eycken, Johan;Cos, Paul;Munier-Lehmann, Helene;Van Calenbergh, Serge. And the article was included in Bioorganic & Medicinal Chemistry in 2016.Reference of 85838-94-4 This article mentions the following:
We report the design and synthesis of a series of non-nucleoside MtbTMPK inhibitors (1-14) based on the gram-pos. bacterial TMPK inhibitor hit compound 1. A practical synthesis was developed to access these analogs. Several compounds show promising MtbTMPK inhibitory potency and allow the establishment of a structure-activity relationship, which is helpful for further optimization. In the experiment, the researchers used many compounds, for example, tert-Butyl 5,6-dihydropyridine-1(2H)-carboxylate (cas: 85838-94-4Reference of 85838-94-4).
tert-Butyl 5,6-dihydropyridine-1(2H)-carboxylate (cas: 85838-94-4) belongs to pyridine derivatives. Pyridine has a dipole moment and a weaker resonant stabilization than benzene (resonance energy 117 kJ璺痬ol閳? in pyridine vs. 150 kJ璺痬ol閳? in benzene). Pyridine derivatives are also useful as small-molecule 浼?helix mimetics that inhibit protein-protein interactions, as well as functionally selective GABA ligands.Reference of 85838-94-4